No Data
No Data
The prospects for embodied AI are broad! A report from Morgan Stanley: focusing on the humanoid robot disruptor Mentee, the China and U.S. markets nurture a trillion-dollar opportunity.
Morgan Stanley has released the latest research report, exploring how embodied AI can help the humanoid robot market reach new heights, with a focus on the Israeli startup Mentee Robotics.
Jefferies Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating, Maintains Target Price $77
Stocks That Could Be Safe From Tariffs Risk Compared to Their Industry Peers
Morgan Stanley Fund: Humanoid robots will gradually enter the mass production phase by 2025.
Currently, the humanoid robot industry both domestically and internationally is mainly divided into three major forces: automotive companies, robot companies, and Internet companies. The primary demand for humanoid robots such as those from Tesla is the ability for scaled production and cost reduction.
Goldman Sachs: The humanoid robot industry may transition from the research and development phase to the mass production phase by 2025.
Goldman Sachs stated that based on the current progress, the Industry may transition from the research and development stage to the mass production stage in 2025.
Procept Biorobotics Earnings Call Highlights Growth and Challenges
Unlock the Full List